Shares of small-cap EV manufacturer Wardwizard Innovations and Mobility (WIML) soared by 20% on the BSE during Monday's trading session, reaching the day’s high of Rs 62.71. This surge was fueled by the company's announcement of securing a $1.29 billion contract from a Philippines-based company, Beulah International Development Corporation.

Shares of Suzlon Energy dropped by 5% during Monday's early session, hitting the day’s low of Rs 47. This decline followed the resignation of the company’s independent director, Marc Desaedeleer, from his directorship on June 8.

In May, FIIs were net sellers, yet invested over Rs 11,000 crore in 4 sectors: capital goods, consumer services, realty, and telecom, ahead of Lok Sabha election results. NSDL data reveals top buys in capital goods at Rs 6,024 crore, followed by consumer services, realty, and telecom. Financial services and IT bore the brunt of FII outflows.

KEC International's share price rose by 8% to Rs 829 after securing new orders worth Rs 1,061 crore. The company's YTD order intake is over Rs 3,000 crores, with a growth of 30% compared to last year.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Nifty extended its pullback and went on to end the day on a robust note.

Bajaj Auto, part of the auto space, doubled investors’ wealth in the last year, hitting a record high in June 2024. Analysts suggest further upside potential with technical indicators supporting the bullish trend.

Global investment bank Morgan Stanley has maintained an overweight rating on Kaynes Technology but raised the target price to Rs 3,845 from Rs 2,440, while Macquarie maintained a sell rating on Zomato with a target price of Rs 100.

A short buildup is when there is a rise in open interest and volumes along with a decrease in the price of the underlying stock in the Futures and Options segment. Short buildup means more people are expecting the prices to go down and creating short positions. In Monday's trading session, five stocks witnessed a build of fresh short positions. Here's the list:

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Nifty extended its pullback and went on to end the day on a robust note.

Bajaj Auto, part of the auto space, doubled investors’ wealth in the last year, hitting a record high in June 2024. Analysts suggest further upside potential with technical indicators supporting the bullish trend.

Global investment bank Morgan Stanley has maintained an overweight rating on Kaynes Technology but raised the target price to Rs 3,845 from Rs 2,440, while Macquarie maintained a sell rating on Zomato with a target price of Rs 100.

A long buildup occurs when there is an increase in open interest and trading volumes alongside a rise in the price of the underlying stock in the Futures and Options segment, indicating a bullish trend in the market. In Monday's trading session, five stocks experienced a buildup of fresh long positions. Here's the list:

Chandrababu Naidu's family's wealth surges with Heritage Foods shares rising over 105%. Naidu's party, Telugu Desam Party, wins big in Andhra Pradesh elections.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Nifty extended its pullback and went on to end the day on a robust note.

Bajaj Auto, part of the auto space, doubled investors’ wealth in the last year, hitting a record high in June 2024. Analysts suggest further upside potential with technical indicators supporting the bullish trend.

Global investment bank Morgan Stanley has maintained an overweight rating on Kaynes Technology but raised the target price to Rs 3,845 from Rs 2,440, while Macquarie maintained a sell rating on Zomato with a target price of Rs 100.

Sebi proposes to revise criteria for derivatives market, potentially adding 78 stocks like LIC, Zomato, YES Bank. Changes include higher thresholds for order size, market-wide position limits, and introducing Product Success Framework for single-stock derivatives after 6 months.

Global investment firm BlackRock likely sold a 15% stake in Mphasis, leading to a 3.7% share price drop. It's the year's second-largest block deal. Blackstone, owning 55.45%, will drop to 40.4% after the deal. Mphasis specializes in IT services, especially in BFSI. Last year, shares rose 27.5%, but in 2024, they fell 13.6%.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Nifty extended its pullback and went on to end the day on a robust note.

Bajaj Auto, part of the auto space, doubled investors’ wealth in the last year, hitting a record high in June 2024. Analysts suggest further upside potential with technical indicators supporting the bullish trend.

Global investment bank Morgan Stanley has maintained an overweight rating on Kaynes Technology but raised the target price to Rs 3,845 from Rs 2,440, while Macquarie maintained a sell rating on Zomato with a target price of Rs 100.

Nifty extended its pullback and went on to end the day on a robust note.

Indian benchmark equity indices, Sensex and Nifty50, reached fresh record highs on Monday with Sensex hitting the 77,000 mark.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

A favourable wealth effect, driven by a sharp rise in the equity markets, is enticing many first-time homebuy ers to take the plunge, while affluent buyers are looking for second homes. If you are a fence-sitter, still unsure about when to buy a house, this market presents a big dilemma. Is it the right time to buy a house?

The longer the tenure of a loan, the higher the interest burden. Home loan rates will not come down as the RBI has kept policy rates unchanged. If you are planning to buy a house with a loan, ET Wealth suggests some ways to reduce the cost of borrowing.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Japan's Nikkei share average edged up on Monday as export-related stocks rose on a weaker yen following stronger-than-expected U.S. jobs data and a rise in domestic yields boosted financial stocks.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

On Friday, equity indices surged by over 2%, reaching record highs following the Reserve Bank of India (RBI) upward revision of the GDP growth projection. Notable stocks included HDFC AMC, which increased by 2%, Wipro, witnessing a 5% gain, and Paytm, whose shares soared by 10% on Friday.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

Investors await next week's inflation data and Fed meeting for signals on stock market trajectory amid conflicting economic signals. S&P 500's 12% YTD rise hinges on Fed's ability to manage inflation without hampering growth.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.

Asian stocks fell as traders reduced bets for Fed rate cuts due to a tight US labor market. A snap election in France raised political concerns, impacting the euro. MSCI's Asia-Pacific shares index also dropped.

Nifty's bullish setup is supported by strong technical indicators, with recommendations for specific stocks in FMCG, pharma, IT, auto, and power sectors for potential gains.

On Friday, the Indian market continued its upward trend, marking the third consecutive day of gains. The S&P BSE Sensex surged by over 1,600 points, while the Nifty50 closed just below the 23,300 level.

Tata Consumer Products, in FMCG space, saw profit-taking but stock up 40% in a year. Rally not over. Stock reached 52-week high of 1269 in March 2024. Analyst recommends accumulating stock in range 1120-1140 for target of 1325-1330 levels with stop loss below 1050. Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own.

Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy's unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.